| Old Articles: <Older 1811-1820 Newer> |
|---|
 |
The Motley Fool
June 27, 2007
Brian Lawler |
Waiting on GPC Exciting development-stage drugmaker GPC's marketing partner files a European marketing application for its top drug.   |
Chemistry World
June 25, 2007
Arthur Rogers |
Golden Opportunity to Halt Quicksilver Trade The European Parliament is supporting plans to ban exports of mercury. Politicians hope such a ban would curb hazards in the developing world created by the use of mercury in activities such as wildcat gold mining. |
The Motley Fool
June 25, 2007
Toby Shute |
A Green Plastics Twofer Metabolix's sugar-based plastics patent is upheld in Germany and Brazil's Braskem enters the fray with its announcement of a 100% renewable polyethylene. Investors, take note. |
Entrepreneur
July 2007
Mark Henricks |
London 2.0 Five years after he co-founded online ticket reseller StubHub Inc. in San Francisco in 2000, Eric Baker wanted to bring the same business model to Europe. |
Chemistry World
June 22, 2007
Ned Stafford |
Big Pharma Not Interested in 'Male Pill' German drug giant Bayer has officially stopped research and development of a hormonal male contraceptive, yet another sign that the pharma industry has lost interest in developing the so-called 'male pill.' |
InternetNews
June 22, 2007
Clint Boulton |
EU Expands Search Engine Scrutiny The European Union's data protection party probe said it is investigating any Internet search engine it feels is guilty of storing data for too long. |
The Motley Fool
June 21, 2007
David Lee Smith |
Russia's Latest Bad Habit The Russian government has returned to making select "acquisitions." BP is only the latest in a string of Western integrated companies that have initiated production projects in Russia, only to have their hosts begin to play hardball as time passed and energy prices rose. |
The Motley Fool
June 21, 2007
Rick Aristotle Munarriz |
Oakley's Made in the Shades Sunglass maker Oakley caves in to Ray-Ban's pricey buyout. The Italian eyewear company is snapping up Oakley in a $2.1 billion deal that will cash out shareowners at $29.30 a pop. |
Chemistry World
June 18, 2007
James Mitchell Crow |
ICI Rejects Bid ICI has rejected a 7.2 billion-pound bid from Dutch chemical firm Akzo Nobel, the British chemical company has revealed. |
The Motley Fool
June 18, 2007
Billy Fisher |
Elan Elevates Its Game New drug prospects push the Dublin-based biotech's shares to a new 52-week high. |
| <Older 1811-1820 Newer> Return to current articles. |
